Biotech Startups

BC Platforms provides AI-enabled, federated data technology and predictive analytics that give healthcare and life sciences organizations access to real-world patient and genomic data for drug development and precision medicine. It serves pharmaceutical companies and healthcare organizations across the US, Europe, Asia-Pacific, and the Middle East.

3 investors

Becoming.ai develops robotic closed-loop hardware that sustains mammalian development externally—regulating nutrients, waste, and gas exchange—paired with AI models that learn to predict how development unfolds and responds to intervention. The platform combines biology, robotics, and machine learning to make developmental processes testable and predictable, targeting research into developmental disease.

3 investors

Clinical-stage biopharmaceutical company developing controllable cell therapies, including next-generation CAR-T, TCR and allogeneic T cell products such as rivo-cel and the GoCAR-T candidate BPX-601.

3 investors

Bexorg is a biotech platform for CNS drug discovery built on a whole-brain perfusion model that allows manipulation and recording of cellular activity in intact human brains. The company serves pharmaceutical researchers developing treatments for brain diseases.

3 investors

Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types. The compound demonstrates clinical benefit in extending overall survival and reducing severe chemotherapy-related neutropenia.

3 investors

BigOmics develops interactive platforms for life scientists to analyze omics data, enabling researchers to process and visualize experimental results in minutes rather than weeks. The company serves academic laboratories and enterprise life science organizations seeking to accelerate discovery through data-driven precision medicine.

3 investors

BioAtla develops novel monoclonal antibody and cell-based therapeutics for cancer treatment using proprietary platforms including Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!). The company aims to create biologics with improved selectivity for tumor tissue and enhanced therapeutic index.

3 investors

Biocollabs offers the Alcohol Belly Protocol, a plant-based liquid supplement designed to support liver function and reduce visceral fat accumulation in people who consume alcohol. The product targets metabolic health and weight loss through improved liver enzyme activity and fat metabolism.

3 investors

BioCorteX develops personalized therapeutics using a microbiome knowledge graph and proprietary biology emulation platform to tailor drug treatments for diverse populations. The company aims to improve treatment efficacy across different communities by accounting for individual microbiome variations in drug development.

3 investors

BioFeyn is a life sciences company that applies biomedical nanoencapsulation technology (its "Feyn" delivery mechanism) to feed ingredients, improving nutrient absorption and bioavailability in animals. It focuses on aquaculture and agriculture, particularly salmon farming, serving farmers and feed suppliers while reducing waste and environmental impact.</parameter> <parameter name="founders">[{"full_name": "Timothy Bouley", "title": "CEO, Founder"}, {"full_name": "Marie-Christine Imbert", "title": "CSO, Founder"}]

3 investors

Biofidelity develops decentralized biomarker testing solutions, starting with Aspyre Lung Reagents for analyzing DNA and RNA variants in lung cancer research. The company enables genomic testing on existing qPCR platforms globally, avoiding the cost and complexity of next-generation sequencing.

3 investors

Biogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.

3 investors

BioGeneration Ventures (BGV) is the early-stage arm of the Forbion-BGV platform of funds, investing in and supporting biotech and life sciences companies across their stages of development. It partners with academic institutions, healthcare and pharma companies, and other venture investors across the Netherlands, EU and US.

3 investors

Biograil is a company backed by venture capital investors specializing in deep tech, sustainable technologies, and life sciences ventures across Europe.

3 investors

BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.

3 investors

BioIntelligence Technologies builds an analytics platform that performs in-situ, simultaneous measurement of products, nutrients and metabolic intermediates with real-time analysis to optimize bioprocess profitability. It serves biotech companies in the transformation industry, targeting pharmaceutical and greener-chemical production.

3 investors

BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.

3 investors

BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology. Its proteins combine an active stimulatory domain with a binding domain to localize therapy at the disease site for targeted, infrequent dosing.

3 investors

Biolojic uses artificial intelligence and machine learning to design programmable antibodies that can dynamically sense and respond to specific patient micro-environments. The company leverages its proprietary dataset of billions of antibody measurements and iterative AI models to engineer antibodies with novel therapeutic capabilities.

3 investors

Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development. It focuses on expanding access to cancer care across Latin America while generating clinical and biospecimen data.

3 investors

Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry. Founded in North Carolina with manufacturing and market development in Denmark, the company sells tile products installed in the US and Europe and is developing pavers and walls, with a focus on the European market.

3 investors

Exact Sciences develops and runs laboratory tests and clinical studies for cancer detection and treatment, serving patients and health care professionals in oncology. Its work centers on cancer screening tests such as a multi-target stool DNA test for colorectal cancer.

3 investors

Biomia is a biotechnology company using biology, chemistry, and pharmacoengineering to develop a new generation of central nervous system (CNS) therapeutics. It focuses on drug discovery to address unmet patient needs.

3 investors

Bioo develops biotech and landscaping solutions that generate electricity and water from natural processes through proprietary technologies, serving clients seeking to integrate nature-based systems into building and urban design projects. The company designs, installs, and maintains installations for institutional and commercial customers.

3 investors